Reuters, Citing CNBC
Needham Reiterates Buy on Engagesmart, Maintains $40 Price Target
Needham analyst Scott Berg reiterates Engagesmart (NYSE:ESMT) with a Buy and maintains $40 price target.
Related Posts
Elon Musk Lawyers Say Twitter Won’t Accept Renewed $44B Bid For The Company, Ask Delaware Court To Halt Upcoming Trial –
- Twitter Source Citing AP News
EXCLUSIVE: SAB Biotherapeutics’ Influenza Immunotherapy Shows Safety, Efficacy In Early-Stage Trials
SAB Biotherapeutics Inc (NASDAQ: SABS) has announced the presentation of safety and efficacy data from Phase 1 and 2a trials of its influenza immunotherapy, SAB-176.
Nasdaq Down Over 1%; Crude Oil Rises Sharply
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Monday.